Published, Version of Record (VoR)CC BY V4.0, Open
Abstract
Genetics & Heredity Life Sciences & Biomedicine Science & Technology
RRM2B plays a crucial role in DNA replication, repair and oxidative stress. While germline RRM2B mutations have been implicated in mitochondrial disorders, its relevance to cancer has not been established. Here, using TCGA studies, we investigated RRM2B alterations in cancer. We found that RRM2B is highly amplified in multiple tumor types, particularly in MYC-amplified tumors, and is associated with increased RRM2B mRNA expression. We also observed that the chromosomal region 8q22.3-8q24, is amplified in multiple tumors, and includes RRM2B, MYC along with several other cancer-associated genes. An analysis of genes within this 8q-amplicon showed that cancers that have both RRM2B-amplified along with MYC have a distinct pattern of amplification compared to cancers that are unaltered or those that have amplifications in RRM2B or MYC only. Investigation of curated biological interactions revealed that gene products of the amplified 8q22.3-8q24 region have important roles in DNA repair, DNA damage response, oxygen sensing, and apoptosis pathways and interact functionally. Notably, RRM2B-amplified cancers are characterized by mutation signatures of defective DNA repair and oxidative stress, and at least RRM2B-amplified breast cancers are associated with poor clinical outcome. These data suggest alterations in RR2MB and possibly the interacting 8q-proteins could have a profound effect on regulatory pathways such as DNA repair and cellular survival, highlighting therapeutic opportunities in these cancers.
RRM2B Is Frequently Amplified Across Multiple Tumor Types: Implications for DNA Repair, Cellular Survival, and Cancer Therapy
Creators
Waleed Iqbal - Fox Chase Cancer Center
Elena V. Demidova - Fox Chase Cancer Center
Samantha Serrao - Fox Chase Cancer Center
Taha ValizadehAslani - Drexel University
Gail Rosen - Drexel University
Sanjeevani Arora - Fox Chase Cancer Center
Publication Details
Frontiers in genetics, v 12, pp 628758-628758
Publisher
Frontiers Media Sa
Number of pages
13
Grant note
Fox Chase Cancer Center Risk Assessment Program Funds
W81XWH-18-1-0148 / DOD; United States Department of Defense
1650531 / NSF; National Science Foundation (NSF)
Resource Type
Journal article
Language
English
Academic Unit
Electrical and Computer Engineering; Pharmacology and Physiology
Web of Science ID
WOS:000632866600001
Scopus ID
2-s2.0-85103320054
Other Identifier
991019168900304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: